Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice

Neurobiology of Stress

Volumn 7, Issue , 2017, Pages 1-15

  Dostal, Carlos R ^a   Carson Sulzer, Megan ^b   Kelley, Keith W ^a,c   Freund, Gregory G ^a,c   McCusker, Robert H ^a,c  

^a Department of Animal Sciences   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Astrocyte; Ido; Kynurenine; Liver; Stress; Tdo

Indexed keywords

DIOXYGENASE; FK 506 BINDING PROTEIN; INTERLEUKIN 1BETA; KYNURENINE; TUMOR NECROSIS FACTOR;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CHEMICAL STRESS; CONTROLLED STUDY; ENRICHMENT CULTURE; FEMALE; FRONTAL CORTEX; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; INFLAMMATION; KNOCKOUT MOUSE; MALE; MICROGLIA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 85013031190     PISSN: None     EISSN: 23522895     Source Type: Journal    
DOI: 10.1016/j.ynstr.2017.02.002     Document Type: Article

References (102)

1. Ando, T., Dunn, A.J., Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 6 (1999), 319–329, 10.1159/000026391.
2. Badawy, A.A.-B., Evans, M., The mechanism of inhibition of rat liver tryptophan pyrrolase activity by 4-hydroxypyrazolo[3,4-d]pyrimidine (Allopurinol). Biochem. J. 133 (1973), 585–591.
3. Ball, H.J., Sanchez-Perez, A., Weiser, S., Austin, C.J.D., Astelbauer, F., Miu, J., McQuillan, J.A., Stocker, R., Jermiin, L.S., Hunt, N.H., Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396 (2007), 203–213, 10.1016/j.gene.2007.04.010.
4. Bender, D.A., Olufunwa, R., Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells. Br. J. Nutr. 59 (1988), 279–287, 10.1079/BJN19880035.
5. Bradley, K.A.L., Case, J.A.C., Khan, O., Ricart, T., Hanna, A., Alonso, C.M., Gabbay, V., The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Res. 227 (2015), 206–212, 10.1016/j.psychres.2015.03.031.
6. Brooks, A.K., Lawson, M.A., Rytych, J.L., Yu, K.C., Janda, T.M., Steelman, A.J., McCusker, R.H., Immunomodulatory factors galectin-9 and interferon-gamma synergize to induce expression of rate-limiting enzymes of the kynurenine pathway in the mouse hippocampus. Front. Immunol. 7 (2016), 1–16, 10.3389/fimmu.2016.00422.
7. Brooks, A.K., Lawson, M.A., Smith, R.A., Janda, T.M., Kelley, K.W., McCusker, R.H., Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus. J. Neuroinflammation 13 (2016), 1–16, 10.1186/s12974-016-0563-1.
8. Browne, C.A., O'Brien, F.E., Connor, T.J., Dinan, T.G., Cryan, J.F., Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience 225 (2012), 237–248, 10.1016/j.neuroscience.2012.08.031.
9. Chiappelli, J., Pocivavsek, A., Nugent, K.L., Notarangelo, F.M., Kochunov, P., Rowland, L.M., Schwarcz, R., Hong, L.E., Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance. JAMA psychiatry 71 (2014), 761–768, 10.1001/jamapsychiatry.2014.243.
10. Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. Jama 267 (1992), 1244–1252, 10.1001/jama.267.9.1244.
11. Curzon, G., Green, A.R., Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br. J. Pharmacol. 37 (1969), 689–697, 10.1111/j.1476-5381.1969.tb08507.x.
12. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56, 10.1038/nrn2297.
13. Dugan, A.M., Parrott, J.M., Redus, L., Hensler, J.G., O'Connor, J.C., Low-level stress induces production of neuroprotective factors in wild-type but not BDNF+/- mice: interleukin-10 and kynurenic acid. Int. J. Neuropsychopharmacol. 19 (2016), 1–5, 10.1093/ijnp/pyv089.
14. Dunn, A.J., The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29 (1992), 807–812.
15. Ensembl, Indoleamine 2,3-dioxygenase 2 [WWW Document]. Ensembl release 87-Dec 2016, 2016 http://useast.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000188676;r=8:39792133–39873910.
16. Ensembl, Indoleamine 2,3-dioxygenase 1 [WWW Document]. Ensembl release 87-Dec 2016, 2016 http://useast.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131203;r=8:39759794–39785963.
17. Ensembl, Tryptophan 2,3-dioxygenase [WWW Document]. Ensembl release 87-Dec 2016, 2016 http://useast.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000151790;r=4:156775890–156841558.
18. Erhardt, S., Schwieler, L., Emanuelsson, C., Geyer, M., Endogenous kynurenic acid disrupts prepulse inhibition. Biol. Psychiatry 56 (2004), 255–260, 10.1016/j.biopsych.2004.06.006.
19. Erhardt, S., Schwieler, L., Imbeault, S., Engberg, G., The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112 (2016), 297–306, 10.1016/j.neuropharm.2016.05.020.
20. Francesconi, R.P., Boyd, A.E. III, Mager, M., Human tryptophan and tyrosine metabolism: effects of acute exposure to cold stress. J. Appl. Physiol. 33 (1972), 165–169.
21. Frank, M.G., Weber, M.D., Watkins, L.R., Maier, S.F., Stress-induced neuroinflammatory priming: a liability factor in the etiology of psychiatric disorders. Neurobiol. Stress 4 (2015), 62–70, 10.1016/j.ynstr.2015.12.004.
22. Fujigaki, H., Saito, K., Fujigaki, S., Takemura, M., Sudo, K., Ishiguro, H., Seishima, M., The signal transducer and activator of transcription 1 and interferon regulatory factor 1α are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kB. J. Biochem. 139 (2006), 655–662, 10.1093/jb/mvj072.
23. Fujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., Seishima, M., Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur. J. Immunol. 31 (2001), 2313–2318, 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S.
24. Fukunaga, M., Yamamoto, Y., Kawasoe, M., Arioka, Y., Murakami, Y., Hoshi, M., Saito, K., Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis. J. Histochem. Cytochem 60 (2012), 854–860, 10.1369/0022155412458926.
25. Gabbay, V., Ely, B.A., Babb, J., Liebes, L., The possible role of the kynurenine pathway in anhedonia in adolescents. J. Neural Transm. 119 (2012), 253–260, 10.1007/s00702-011-0685-7.
26. Gibney, S.M., Fagan, E.M., Waldron, A., O'Byrne, J., Connor, T.J., Harkin, A., Inhibition of stress-induced hepatic tryptophan 2, 3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int. J. Neuropsychopharmacol. 17 (2014), 917–928, 10.1017/S1461145713001673.
27. Gold, P.W., Machado-Vieira, R., Pavlatou, M.G., Clinical and biochemical manifestation of depression: relation to the neurobiology of stress. Neural Plast., 2015, 2015, 11, 10.1155/2015/581976.
28. Guidetti, P., Hoffman, G.E., Melendez-Ferro, M., Albuquerque, E.X., Schwarcz, R., Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55 (2007), 78–92, 10.1002/glia.
29. Guillemin, G.J., Brew, B.J., Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75 (2010), 388–397, 10.1189/jlb.0303114.1.
30. Guillemin, G.J., Kerr, S.J., Smythe, G.A., Smith, D.G., Kapoor, V., Armati, P.J., Croitoru, J., Brew, B.J., Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 78 (2001), 842–853, 10.1046/j.1471-4159.2001.00498.x.
31. Guillemin, G.J., Smith, D.G., Smythe, G.A., Armati, P.J., Brew, B.J., Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv. Exp. Med. Biol. 527 (2003), 105–112.
32. Guillemin, G.J., Smythe, G., Takikawa, O., Brew, B.J., Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia, 2004, 15–23, 10.1002/glia.20090.
33. Herédi, J., Berkó, A.M., Jankovics, F., Iwamori, T., Iwamori, N., Ono, E., Horváth, S., Kis, Z., Toldi, J., Vécsei, L., Gellért, L., Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain. Brain Struct. Funct., 2016, 10.1007/s00429-016-1299-5.
34. Heyes, M.P., Achim, C.L., Wiley, C.A., Major, E.O., Saito, K., Markey, S.P., Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 320:Pt 2 (1996), 595–597.
35. Howes, O.D., McCutcheon, R., Owen, M.J., Murray, R., The role of genes, stress and dopamine in the development of schizophrenia. Biol. Psychiatry 81 (2016), 9–20, 10.1016/j.biopsych.2016.07.014.
36. Inayoshi, Y., Kaneoka, H., Machida, Y., Terajima, M., Dohda, T., Miyake, K., Iijima, S., Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development. J. Biochem. 138 (2005), 457–465, 10.1093/jb/mvi147.
37. Kanai, M., Nakamura, T., Funakoshi, H., Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci. Res. 64 (2009), 111–117, 10.1016/j.neures.2009.02.004.
38. Kennett, G.A., Joseph, M.H., The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology 20 (1981), 39–43.
39. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289 (2003), 3095–3105, 10.1001/jama.289.23.3095.
40. Kessler, R.C., Mcgonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H., Kendler, K.S., Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch. Gen. Psychiatry 51 (1994), 8–19.
41. Kiank, C., Zeden, J.-P., Drude, S., Domanska, G., Fusch, G., Otten, W., Schuett, C., Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PLoS One, 5, 2010, e11825, 10.1371/journal.pone.0011825.
42. Kiss, C., Ceresoli-Borroni, G., Guidetti, P., Zielke, C.L., Zielke, H.R., Schwarcz, R., Kynurenate production by cultured human astrocytes. J. Neural Transm. 110 (2003), 1–14, 10.1007/s00702-002-0770-z.
43. Kolodziej, L., Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis. Transgenic Res. 22 (2013), 1049–1054, 10.1007/s11248-013-9696-5.
44. Kulaeva, O.I., Nizovtseva, E.V., Polikanov, Y.S., Ulianov, S.V., Studitsky, V.M., Distant activation of transcription: mechanisms of enhancer action. Mol. Cell. Biol. 32 (2012), 4892–4897, 10.1128/MCB.01127-12.
45. Kumar, S., Wang, J., Thomson, A.W., Gandhi, C.R., Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation. J. Leukoc. Biol. 101 (2016), 1–10, 10.1189/jlb.2A0516-239R.
46. Kumari, V., Soni, W., Mathews, V.M., Sharma, T., Prepulse inhibition of the startle response in men with schizophrenia. Arch. Gen. Psychiatry 57 (2000), 609–614, 10.1001/archpsyc.57.6.609.
47. Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., Bechmann, I., Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19 (2005), 1347–1349, 10.1096/fj.04-3228fje.
48. Lawson, M., Kelley, K.W., Dantzer, R., Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain. Behav. Immun. 25 (2011), 1569–1575, 10.1016/j.bbi.2011.05.006.
49. Lawson, M.A., Dostal, C.R., Brooks, A.K., McCusker, R.H., The Kynurenine (Kyn) Pathway and Neuroinflammation: the Confused Brain. Opp, M.R., (eds.), 2016, Primer of PsychoNeuroImmunology Research, Los Angeles, CA, 95–101.
50. Lee, Y.-K., Lee, H.B., Shin, D.-M., Kang, M.J., Yi, E.C., Noh, S., Lee, J., Lee, C., Min, C.-K., Choi, E.Y., Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2. Exp. Mol. Med., 46, 2014, e121, 10.1038/emm.2014.69.
51. Liu, Y.-N., Peng, Y.-L., Lei-Liu, Wu, T.-Y., Zhang, Y., Lian, Y.-J., Yang, Y.-Y., Kelley, K.W., Jiang, C.-L., Wang, Y.-X., TNFα mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur. Cytokine Netw. 26 (2015), 15–25, 10.1016/j.rasd.2014.08.015.Social.
52. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408, 10.1006/meth.2001.1262.
53. Madrigal, J.L.M., Hurtado, O., Moro, M.A., Lizasoain, I., Lorenzo, P., Castrillo, A., Boscá, L., Leza, J.C., The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26 (2002), 155–163, 10.1016/S0893-133X(01)00292-5.
54. Mazarei, G., Budac, D.P., Lu, G., Lee, H., Möller, T., Leavitt, B.R., The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Exp. Neurol. 249 (2013), 144–148, 10.1016/j.expneurol.2013.08.007.
55. McCusker, R.H., Kavelaars, A., Heijnen, C.J., Dantzer, R., Kelley, K.W., Depression, inflammation and tryptophan metabolism. Kusnecov, A., Anisman, H., (eds.) The Wiley-Blackwell Handbook of Psychoneuroimmunology, 2014, John Wiley & Sons, Ltd, 448–468.
56. McEwen, B.S., Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 (2007), 873–904, 10.1152/physrev.00041.2006.
57. Merlo, L.M.F., Mandik-Nayak, L., IDO2: a pathogenic mediator of inflammatory autoimmunity. Clin. Med. Insights Pathol. 9 (2016), 21–28, 10.4137/CPath.S39930.TYPE.
58. Metz, R., DuHadaway, J.B., Kamasani, U., Laury-Kleintop, L., Muller, A.J., Prendergast, G.C., Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67 (2007), 7082–7087, 10.1158/0008-5472.CAN-07-1872.
59. Metz, R., Smith, C., DuHadaway, J.B., Chandler, P., Baban, B., Merlo, L.M.F., Pigott, E., Keough, M.P., Rust, S., Mellor, A.L., Mandik-Nayak, L., Muller, A.J., Prendergast, G.C., IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int. Immunol. 26 (2014), 357–367, 10.1093/intimm/dxt073.
60. Miller, C.L., Llenos, I.C., Dulay, J.R., Barillo, M.M., Yolken, R.H., Weis, S., Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol. Dis. 15 (2004), 618–629, 10.1016/j.nbd.2003.12.015.
61. Miller, C.L., Llenos, I.C., Dulay, J.R., Weis, S., Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 1073–1074 (2006), 25–37, 10.1016/j.brainres.2005.12.056.
62. Miura, H., Ando, Y., Noda, Y., Isobe, K., Ozaki, N., Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice. Stress 14 (2011), 262–272, 10.3109/10253890.2010.541539.
63. Miura, H., Ando, Y., Noda, Y., Ozaki, N., Isobe, K., Effects of minocycline on changes in brain tryptophan metabolism and the behavior of juvenile mice elicited by inescapable-predator stress. J. Trauma. Stress Disord. Treat. 2 (2013), 1–7.
64. Myint, A.M., Schwarz, M.J., Müller, N., The role of the kynurenine metabolism in major depression. J. Neural Transm. 119 (2012), 245–251, 10.1007/s00702-011-0741-3.
65. Nakamura, T., Niimi, S., Nawa, K., Noda, C., Ichihara, A., Takagi, Y., Anai, M., Sakaki, Y., Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J. Biol. Chem. 262 (1987), 727–733.
66. Nakamura, T., Shinno, H., Ichihara, A., Insulin and glucagon as a new regulator system for tryptophan oxygenase activity demonstrated in primary cultured rat hepatocytes. J. Biol. Chem. 255 (1980), 7533–7535.
67. Nemeth, S., The effect of stress on the activity of hepatic tryptophan pyrrolase, of tyrosine aminotransferase in various organs and on the level of tryptophan in the liver and plasma of rats. Physiol. Bohemoslov. 26 (1976), 557–563.
68. Nguyen, K.T., Deak, T., Owens, S.M., Kohno, T., Fleshner, M., Watkins, L.R., Maier, S.F., Exposure to acute stress induces brain Interleukin-1β protein in the rat. J. Neurosci. 18 (1998), 2239–2246.
69. Nguyen, K.T., Deak, T., Will, M.J., Hansen, M.K., Hunsaker, B.N., Fleshner, M., Watkins, L.R., Maier, S.F., Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress. Brain Res. 859 (2000), 193–201, 10.1016/S0006-8993(99)02443-9.
70. Niimi, S., Nakamura, T., Nawa, K., Ichihara, A., Hormonal regulation of translatable mRNA of tryptophan 2,3-dioxygenase in primary cultures of adult rat hepatocytes. J. Biochem. 94 (1983), 1697–1706.
71. Noda, C., Nakamura, T., Ichihara, A., alpha-Adrenergic regulation of enzymes of amino acid metabolism in primary cultures of adult rat hepatocytes. J. Biol. Chem. 258 (1983), 1520–1525.
72. Nomura, J., Effects of stress and psychotropic drugs on rat liver tryptophan. Endocrinology 76 (1965), 1190–1194, 10.1210/endo-76-6-1190.
73. O'Connor, J.C., André, C., Wang, Y., Lawson, M., Szegedi, S.S., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 29 (2009), 4200–4209, 10.1523/JNEUROSCI.5032-08.2009.
74. O'Connor, J.C., Lawson, M.A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 14 (2009), 511–522, 10.1038/sj.mp.4002148.
75. O'Farrell, K., Harkin, A., Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders. Neuropharmacology, 2015, 10.1016/j.neuropharm.2015.12.004.
76. Ohgidani, M., Kato, T.A., Sagata, N., Hayakawa, K., Shimokawa, N., Sato-Kasai, M., Kanba, S., TNF-α from hippocampal microglia induces working memory deficits by acute stress in mice. Brain. Behav. Immun. 55 (2016), 17–24, 10.1016/j.bbi.2015.08.022.
77. Ohta, Y., Kubo, H., Yashiro, K., Ohashi, K., Tsuzuki, Y., Wada, N., Yamamoto, Y., Saito, K., Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues. J. Physiol. Sci., 2016, 1–12, 10.1007/s12576-016-0467-y.
78. Ott, M., Litzenburger, U.M., Rauschenbach, K.J., Bunse, L., Ochs, K., Sahm, F., Pusch, S., Opitz, C.A., Blaes, J., von Deimling, A., Wick, W., Platten, M., Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia 63 (2015), 78–90, 10.1002/glia.22734.
79. Pallotta, M.T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M.L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., Mazza, E.M.C., Boon, L., Grassi, F., Fioretti, M.C., Fallarino, F., Puccetti, P., Grohmann, U., Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12 (2011), 870–878, 10.1038/ni.2077.
80. Parrott, J.M., Redus, L., O'Connor, J.C., Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. J. Neuroinflammation 13 (2016), 1–15, 10.1186/s12974-016-0590-y.
81. Pawlak, D., Takada, Y., Urano, T., Takada, A., Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res. Bull. 52 (2000), 197–205, 10.1016/S0361-9230(00)00252-5.
82. Pocivavsek, A., Notarangelo, F.M., Wu, H.-Q., Bruno, J.P., Schwarcz, R., Astrocytes as pharmacological targets in the treatment of schizophrenia: focus on kynurenic acid. Pletnikov, M.V., Waddington, J.L., (eds.) Handbook of Behavioral Neuroscience, 2016, Elsevier, 423–443, 10.1016/B978-0-12-800981-9.00025-0.
83. Potter, M.C., Elmer, G.I., Bergeron, R., Albuquerque, E.X., Guidetti, P., Wu, H.-Q., Schwarcz, R., Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 35 (2010), 1734–1742, 10.1038/npp.2010.39.
84. Raison, C.L., Dantzer, R., Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., Spivey, J.R., Saito, K., Miller, A.H., CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 15 (2010), 393–403, 10.1038/mp.2009.116.
85. Rossi, F., Schwarcz, R., Rizzi, M., Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis. Curr. Opin. Struct. Biol. 18 (2008), 748–755, 10.1016/j.sbi.2008.09.009.
86. Schwarcz, R., Rassoulpour, A., Wu, H.Q., Medoff, D., Tamminga, C.A., Roberts, R.C., Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50 (2001), 521–530, 10.1016/S0006-3223(01)01078-2.
87. Sery, O., Sultana, N., Kashem, M.A., Pow, D.V., Balcar, V.J., GLAST but not least — distribution, function, genetics and epigenetics of L-glutamate transport in brain—focus on GLAST/EAAT1. Neurochem. Res., 2015, 2461–2472, 10.1007/s11064-015-1605-2.
88. Shimazu, T., Role of hypothalamus in the induction of tryptophan pyrrolase activity in rabbit liver. J. Biochem. 55 (1964), 163–171.
89. Shimazu, T., The effect of electric stimulation of hypothalamus on rabbit liver tryptophan pyrrolase. Biochim. Biophys. Acta 65 (1962), 373–375.
90. Sorrells, S.F., Caso, J.R., Munhoz, C.D., Sapolsky, R.M., The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 64 (2009), 33–39, 10.1016/j.neuron.2009.09.032.
91. Sorrells, S.F., Sapolsky, R.M., An inflammatory review of glucocorticoid actions in the CNS. Brain. Behav. Immun. 21 (2007), 259–272, 10.1016/j.bbi.2006.11.006.
92. Stechschulte, L.A., Sanchez, E.R., FKBP51-A selective modulator of glucocorticoid and androgen sensitivity. Curr. Opin. Pharmacol. 11 (2011), 332–337, 10.1016/j.coph.2011.04.012.
93. Steelman, A.J., Alford, E., Young, C.R., Welsh, T.H., Meagher, M.W., Welsh, C.J.R., Restraint stress fails to render C57BL/6 mice susceptible to theiler's virus-induced demyelination. Neuroimmunomodulation 17 (2010), 109–119, 10.1159/000258694.
94. Vecchiarelli, H.A., Gandhi, C.P., Hill, M.N., Acute psychological stress modulates the expression of enzymes involved in the Kynurenine Pathway throughout corticolimbic circuits in adult male rats. Neural Plast. 2016 (2015), 1–12, 10.1155/2016/7215684.
95. Wang, Y., Lawson, M., Dantzer, R., Kelley, K.W., LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain. Behav. Immun. 24 (2010), 201–209, 10.1016/j.bbi.2009.06.152.
96. Weidenauer, A., Bauer, M., Sauerzopf, U., Bartova, L., Praschak-Rieder, N., Sitte, H.H., Kasper, S., Willeit, M., Making sense of: sensitization in schizophrenia. Int. J. Neuropsychopharmacol. 00 (2016), 1–10, 10.1093/ijnp/pyw081.
97. Won, E., Kim, Y.-K., Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression. Curr. Neuropharmacol., 2015, 1–8.
98. Wu, H.-Q., Pereira, E.F.R., Bruno, J.P., Pellicciari, R., Albuquerque, E.X., Schwarcz, R., The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J. Mol. Neurosci. 40 (2010), 204–210, 10.1007/s12031-009-9235-2.
99. Yadav, M.C., Burudi, E.M.E., Alirezaei, M., Flynn, C.C., Watry, D.D., Lanigan, C.M., Fox, H.S., IFN-gamma-induced Ido and Wrs expression in microglia is differentially regulated by IL-4. Glia 55 (2007), 1416–1425, 10.1002/glia.
100. Zannas, A.S., Wiechmann, T., Gassen, N.C., Binder, E.B., Gene–stress–epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41 (2016), 261–274, 10.1038/npp.2015.235.
101. Zhai, L., Dey, M., Lauing, K.L., Gritsina, G., Kaur, R., Lukas, R.V., Nicholas, M.K., Rademaker, A.W., Dostal, C.R., McCusker, R.H., Raizer, J.J., Parsa, A.T., Block, O., Wainwright, D.A., The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy. J. Clin. Neurosci. 22 (2015), 1964–1968.
102. Zmarowski, A., Wu, H.Q., Brooks, J.M., Potter, M.C., Pellicciari, R., Schwarcz, R., Bruno, J.P., Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur. J. Neurosci. 29 (2009), 529–538, 10.1111/j.1460-9568.2008.06594.x.